Insider Trading History of Malik Rajesh

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Malik Rajesh since 2018. This trader's CIK number is 1706853. At the time of last reporting, Malik Rajesh was the Chief Medical Officer of G1 Therapeutics, Inc.. (stock ticker symbol GTHX). Also see all insider trading activities at G1 Therapeutics, Inc..

Note that in the past Malik Rajesh also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Point Biopharma Global Inc. (PNT) by Malik Rajesh

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 PNT 3,700 $24,642 0 $0 0 $0

Yearly summary of insider trading at G1 Therapeutics, Inc. (GTHX) by Malik Rajesh

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 GTHX 0 $0 42,966 $188,911 28,600 $8,580
2023 GTHX 0 $0 3,729 $16,420 0 $0
2022 GTHX 0 $0 2,093 $18,685 10,000 $3,000
2021 GTHX 0 $0 60,000 $1,313,925 63,100 $109,659
2020 GTHX 0 $0 9,000 $180,549 16,500 $40,455
2019 GTHX 0 $0 0 $0 7,000 $2,730
2018 GTHX 0 $0 45,312 $1,830,440 60,012 $163,252


Insider trading activities at 2 companies by Malik Rajesh:

1. Point Biopharma Global Inc. (PNT)

2. G1 Therapeutics, Inc. (GTHX)

Table 1. Insider trading of Point Biopharma Global Inc. (PNT) by Malik Rajesh

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-11-28 PNT Buy 3,700 6.66 24,642

Table 2. Insider trading of G1 Therapeutics, Inc. (GTHX) by Malik Rajesh

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-07-05 GTHX Sale 2,475 2.51 6,207
2024-05-13 GTHX Sale 8,151 4.79 39,035
2024-02-12 GTHX Sale 28,600 4.62 132,132
2024-02-12 GTHX Option Ex 28,600 .30 8,580
2024-01-03 GTHX Sale 3,019 3.12 9,416
2024-01-04 GTHX Sale 721 2.94 2,121
2023-07-05 GTHX Sale 1,361 2.45 3,339
2023-01-05 GTHX Sale 729 5.41 3,942
2023-01-04 GTHX Sale 1,639 5.58 9,139
2022-07-05 GTHX Sale 648 5.17 3,351
2022-02-01 GTHX Option Ex 10,000 .30 3,000
2022-01-05 GTHX Sale 1,445 10.61 15,334
2021-04-22 GTHX Option Ex 15,000 .39 5,850
2021-04-22 GTHX Sale 15,000 22.07 331,095
2021-03-23 GTHX Option Ex 15,000 .39 5,850
2021-03-23 GTHX Sale 15,000 21.94 329,055
2021-03-02 GTHX Option Ex 15,000 2.28 34,200
2021-03-02 GTHX Sale 15,000 22.95 344,190
2021-01-27 GTHX Option Ex 3,100 .39 1,209
2021-01-22 GTHX Sale 15,000 20.64 309,585
2021-01-22 GTHX Option Ex 15,000 4.17 62,550
2020-12-10 GTHX Option Ex 9,000 4.17 37,530
2020-12-10 GTHX Sale 9,000 20.06 180,549
2020-03-13 GTHX Option Ex 2,500 .39 975
2020-01-23 GTHX Option Ex 5,000 .39 1,950
2019-01-28 GTHX Option Ex 7,000 .39 2,730
2018-12-17 GTHX Option Ex 3,776 4.17 15,745
2018-12-17 GTHX Sale 3,776 30.00 113,280
2018-11-15 GTHX Option Ex 3,776 4.17 15,745
2018-11-15 GTHX Sale 3,776 40.01 151,092
2018-10-15 GTHX Sale 3,776 41.41 156,356
2018-10-15 GTHX Option Ex 10,076 2.28 22,973
2018-09-17 GTHX Sale 3,776 66.83 252,357
2018-09-17 GTHX Option Ex 3,776 4.17 15,745
2018-08-15 GTHX Option Ex 3,776 4.17 15,745
2018-08-15 GTHX Sale 3,776 55.94 211,233
2018-07-16 GTHX Option Ex 3,776 4.17 15,745
2018-07-16 GTHX Sale 3,776 42.30 159,743
2018-06-15 GTHX Sale 3,776 44.31 167,325
2018-06-15 GTHX Option Ex 3,776 4.17 15,745
2018-06-08 GTHX Option Ex 4,200 .39 1,638
2018-05-15 GTHX Sale 3,776 46.48 175,504
2018-05-15 GTHX Option Ex 3,776 4.17 15,745
2018-04-16 GTHX Option Ex 3,776 4.17 15,745
2018-04-16 GTHX Sale 3,776 36.33 137,185
2018-03-15 GTHX Sale 3,776 38.18 144,152
2018-03-15 GTHX Option Ex 3,776 2.28 8,609
2018-03-08 GTHX Option Ex 4,200 .39 1,638
2018-02-15 GTHX Option Ex 3,776 .34 1,302
2018-02-15 GTHX Sale 3,776 20.00 75,520
2018-01-16 GTHX Sale 3,776 22.96 86,693
2018-01-16 GTHX Option Ex 3,776 .30 1,132

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Malik Rajesh (Chief Medical Officer of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.